FGF22-IN-1

CAS No. 113143-13-8

FGF22-IN-1( —— )

Catalog No. M36498 CAS No. 113143-13-8

FGF22-IN-1 is a potential CD4 N-terminal immunoglobulin variable region-like domain (CD4 D1) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 101 In Stock
10MG 163 In Stock
25MG 312 In Stock
50MG 500 In Stock
100MG 712 In Stock
200MG Get Quote In Stock
500MG 1442 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    FGF22-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    FGF22-IN-1 is a potential CD4 N-terminal immunoglobulin variable region-like domain (CD4 D1) inhibitor.
  • Description
    FGF22-IN-1 (compound c1) is a potent CD4 D1 inhibitor. FGF22-IN-1 can be used as immunosuppressive agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    113143-13-8
  • Formula Weight
    269.32
  • Molecular Formula
    C14H11N3OS
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (371.31 mM; Ultrasonic )
  • SMILES
    O=C(NN=CC1=CNC=2C=CC=CC12)C=3SC=CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xiao H, et al. Potent inhibition of the CD4-dependent T cell response by J2, a novel nonpeptide organic ligand of CD4 D1. Mol Immunol. 2007 Feb;44(5):784-95.?
molnova catalog
related products
  • [Tyr4]-Bombesin

    [Tyr4]-Bombesin is a Bombesin analogue, is a ligand of gastrin-releasing peptide receptor (GRPR).

  • Gadolinium(III) chlo...

    Gadolinium(III) chloride hexahydrate is a contrast agent in magnetic resonance imaging and can be used in medicine, magnetic resonance imaging, liquid crystal displays and other fields.

  • Halopemide

    Halopemide is a potent inhibitor of PLD (IC50 = 220 and 310 nM for human PLD1 and PLD2). Halopemid is an antagonist of dopamine receptors. Halopemid can be used in psychotropic research.